MedTrace Logo

Vitamin D Versus Sildenafil Citrate in Fetal Growth Restriction

NCT06565728 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-08-22

No results posted yet for this study

Summary

Fetal growth restriction, also named Intrauterine growth restriction is a prevalent disease in pregnancy , it is a descriptive term for a pathological process, and can be described as the process where a fetus who has a certain growth potential based on genetic criteria is limited in its growth because of a pathological environmental influence

Conditions

  • Fetal Growth Retardation

Interventions

DRUG

Vitamin D3 2000 UNT Oral Tablet

To assess the role of vitamin D3, versus sildenafil citrate, versus control group in pregnancies complicated by fetal growth restriction

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Omneya Mostafa Helal, Professor · Department of Obstetrics and gynecology. Faculty of Medicine, Cairo University

  • Marwa Mohamed Mahmoud Eid, M.D · Department of Obstetrics and gynecology. Faculty of Medicine, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-03
Primary Completion
2023-05-01
Completion
2023-05-06

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06565728 on ClinicalTrials.gov